Login
$CSBR
$4.56 -$0.15 (3.08%) Live

$CSBR 8-K SEC Filings

Filed On Filing
16 Oct 2026 8-K: Submission of Matters to a Vote of Security Holders

On October 14, 2026, Champions Oncology, Inc. (the “Company”) held its Annual Meeting of Stockholders (the “Annual Meeting”). The following matters were submitted to a vote of the stockholders at the Annual Meeting and the voting results...

10 Sep 2026 8-K: Results of Operations and Financial Condition

One University Plaza, Suite 307 Hackensack, NJ 07601 Tel: 551-206-8104

27 Jul 2026 8-K: Results of Operations and Financial Condition

Delivers Fourth Consecutive Quarter of Positive Adjusted EBITDA

30 Mar 2026 8-K: Departure/Election of Directors or Officers; Compensation

One University Plaza, Suite 307 Hackensack, NJ 07601 Tel: 551-206-8104

12 Mar 2026 8-K: Results of Operations and Financial Condition

One University Plaza, Suite 307 Hackensack, NJ 07601 Tel: 551-206-8104

15 Dec 2025 8-K: Results of Operations and Financial Condition

One University Plaza, Suite 307 Hackensack, NJ 07601 Tel: 551-206-8104

16 Oct 2025 8-K: Submission of Matters to a Vote of Security Holders

On October 16, 2025, Champions Oncology, Inc. (the “Company”) held its Annual Meeting of Stockholders (the “Annual Meeting”). The following matters were submitted to a vote of the stockholders at the Annual Meeting and the voting results...

15 Sep 2025 8-K: Results of Operations and Financial Condition

One University Plaza, Suite 307 Hackensack, NJ 07601 Tel: 551-206-8104

23 Jul 2025 8-K: Results of Operations and Financial Condition

Hackensack, NJ – July 23, 2025 – Champions Oncology, Inc. (Nasdaq: CSBR), a leading translational oncology research organization, today announced its financial results for the fiscal year and fourth quarter ended April 30, 2025.

21 Jul 2025 8-K: Financial Statements and Exhibits

THIS EMPLOYMENT AGREEMENT (“Agreement”) between Champions Oncology, Inc. (the “Company”), a Delaware corporation, and Robert Brainin (the “Executive”), dated this 16th day of July 2025, effective as of the 16th day of July 2025 (the “Eff...

11 Mar 2025 8-K: Results of Operations and Financial Condition

One University Plaza, Suite 307 Hackensack, NJ 07601 Tel: 551-206-8104

11 Dec 2024 8-K: Results of Operations and Financial Condition

One University Plaza, Suite 307 Hackensack, NJ 07601 Tel: 551-206-8104

15 Oct 2024 8-K: Submission of Matters to a Vote of Security Holders

On October 14, 2024, Champions Oncology, Inc. (the “Company”) held its Annual Meeting of Stockholders (the “Annual Meeting”). The following matters were submitted to a vote of the stockholders at the Annual Meeting and the voting results...

03 Oct 2024 8-K: Departure/Election of Directors or Officers; Compensation

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

11 Sep 2024 8-K: Results of Operations and Financial Condition

One University Plaza, Suite 307 Hackensack, NJ 07601 Tel: 551-206-8104

18 Jul 2024 8-K: Results of Operations and Financial Condition

Hackensack, NJ – July 18, 2024 – Champions Oncology, Inc. (Nasdaq: CSBR), a leader in the development of advanced preclinical oncology solutions, today announced its financial results for the fiscal year and fourth quarter ended April 30...

12 Mar 2024 8-K: Results of Operations and Financial Condition

One University Plaza, Suite 307 Hackensack, NJ 07601 Tel: 551-206-8104

12 Dec 2023 8-K: Results of Operations and Financial Condition

One University Plaza, Suite 307 Hackensack, NJ 07601 Tel: 551-206-8104

19 Oct 2023 8-K: Submission of Matters to a Vote of Security Holders

On October 19, 2023, Champions Oncology, Inc. (the “Company”) held its Annual Meeting of Stockholders (the “Annual Meeting”). The following matters were submitted to a vote of the stockholders at the Annual Meeting and the voting results...

17 Oct 2023 8-K: Departure/Election of Directors or Officers; Compensation

One University Plaza, Suite 307 Hackensack, NJ 07601 Tel: 551-206-8104

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support